Shenzhen Gebija Molecular Medicine Innovation Center

Shenzhen Gebijia Molecular Drug Innovation Center (also known as the National Molecular Drug Innovation Center) is a state-level manufacturing innovation center in China, established in December 2024. Operating under a "Company + Alliance" model, the center is led by Shenzhen Gebijia Molecular Drug Innovation Center Co., Ltd., which was co-founded by 17 leading pharmaceutical and biotech companies, including Sunshine Lake Pharma (HEC Pharm), Joinn Laboratories, and Kangtai Biologicals. The center focuses on key common technologies in chemical drugs, biological drugs, and advanced formulations, including nucleic acid drug delivery, dry powder inhalation, long-acting formulations, and cell therapies. It has established a unique Chinese medicine small nucleic acid drug R&D platform and a DNA-encoded chemical library (DEL) containing billions of compounds to accelerate drug discovery and reduce costs.